HALO EBITDA | HALOZYME THERAPEUTICS, INC.

HALOZYME THERAPEUTICS, INC. (HALO) EBITDA

2026-06-30: Basis Reported; EBITDA $292.15M; Operating income (m); Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA $188.74M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$89.59M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $220.62M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$292.15M	(m)	(m)	(m)	60.74%	$4.17M*	$240.89M*	$79.17M	$27.66M	$57.00M	$54.99M
2026-03-31	Reported	$188.74M	(m)	(m)	(m)	50.10%	$3.74M	$180.08M	$79.24M	$25.56M	$57.88M	$30.28M
2025-12-31	Reported	-$89.59M	(m)	(m)	(m)	-19.83%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$220.62M	(m)	(m)	(m)	62.28%	$3.03M*	$178.60M*	$55.24M	$17.25M	$46.09M	$43.73M
2025-06-30	Reported	$205.14M	(m)	(m)	(m)	62.98%	$1.56M*	$99.71M*	$46.36M	$17.54M	$41.61M	$39.78M
2025-03-31	Reported	$144.22M	(m)	(m)	(m)	54.45%	$950.00K	$154.22M	$48.40M	$14.80M	$42.36M	$25.73M
2024-12-31	Reported	$178.15M	(m)	(m)	(m)	59.78%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$165.8M	(m)	(m)	(m)	57.15%	$1.52M*	$115.38M*	$49.43M	$18.46M	$41.24M	$28.14M
2024-06-30	Reported	$119.84M	(m)	(m)	(m)	51.80%	$2.58M*	$55.79M*	$39.61M	$21.04M	$35.71M	$24.50M
2024-03-31	Reported	$97.99M	(m)	(m)	(m)	50.02%	$3.54M	$129.43M	$28.33M	$19.11M	$35.13M	$19.20M
2023-12-31	Reported	$103.97M	(m)	(m)	(m)	45.19%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$90.98M	(m)	(m)	(m)	42.11%	$2.94M*	$132.41M*	$54.82M	$17.32M	$35.27M	$19.92M
2023-06-30	Reported	$97.26M	(m)	(m)	(m)	44.00%	-$1.62M*	$66.84M*	$50.07M	$19.73M	$38.95M	$18.40M
2023-03-31	Reported	$56.42M	(m)	(m)	(m)	34.80%	$11.38M	$86.96M	$35.17M	$17.98M	$37.36M	$12.62M
2022-12-31	Reported	$77.07M	(m)	(m)	(m)	42.46%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$85.29M	(m)	(m)	(m)	40.81%	$1.01M*	$69.64M*	$47.32M	$16.70M	$34.47M	$12.07M
2022-06-30	Reported	$35.16M	(m)	(m)	(m)	23.08%	$968.00K*	$40.23M*	$33.94M	$15.48M	$57.48M	$7.33M
2022-03-31	Reported	$76.45M	(m)	(m)	(m)	65.18%	$490.00K	$47.80M	$15.92M	$11.85M	$13.83M	$14.30M
2021-12-31	Reported	$57.31M	(m)	(m)	(m)	56.18%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$76.29M	(m)	(m)	(m)	65.86%	$496.00K*	$121.74M*	$18.59M	$8.49M	$13.17M	-$142.48M
2021-06-30	Reported	$93.85M	(m)	(m)	(m)	68.78%	$533.00K*	$36.89M*	$23.02M	$8.07M	$12.32M	$58.00K
2021-03-31	Reported	$51.47M	(m)	(m)	(m)	57.82%	$270.00K	$58.30M	$18.22M	$9.01M	$11.06M	$191.00K
2020-12-31	Reported	$78.42M	(m)	(m)	(m)	64.44%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$41.1M	(m)	(m)	(m)	62.92%	$176.00K*	$6.08M*	$5.57M	$7.75M	$11.70M	$63.00K
2020-06-30	Reported	$30.36M	(m)	(m)	(m)	54.97%	$515.00K*	$3.29M*	$5.74M	$8.95M	$10.97M	$58.00K
2020-03-31	Reported	-$2.37M	(m)	(m)	(m)	-9.33%	$114.00K	-$4.84M	$5.79M	$10.16M	$12.63M	$11.00K
2019-12-31	Reported	-$31.02M	(m)	(m)	(m)	-57.80%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$23.54M	(m)	(m)	(m)	-50.91%	$1.10M*	-$29.59M*	$22.33M	$30.45M	$17.98M	$13.00K
2019-06-30	Reported	-$12.98M	(m)	(m)	(m)	-33.15%	$1.37M*	-$24.79M*	$1.88M	$33.91M	$17.34M	$17.00K
2019-03-31	Reported	$3.96M	(m)	(m)	(m)	6.95%	$927.00K	-$4.42M	$4.65M	$31.33M	$18.01M	$22.00K
2018-12-31	Reported	$519,000.00	(m)	(m)	(m)	0.86%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$24.87M	(m)	(m)	(m)	-97.33%	$333.00K*	-$18.93M*	$626.00K	$35.54M	$14.86M	$0.00
2018-06-30	Reported	-$19.47M	(m)	(m)	(m)	-55.32%	$418.00K*	-$18.86M*	$836.00K	$40.09M	$14.35M	$33.00K
2018-03-31	Reported	-$23.15M	(m)	(m)	(m)	-74.97%	$839.00K	-$22.18M	$3.05M	$37.98M	$13.56M	$187.00K
2017-12-31	Reported	$126.42M	(m)	(m)	(m)	66.69%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$8.58M	(m)	(m)	(m)	13.46%	$161.00K*	(m)	(m)	$33.99M	$13.33M	$580.00K
2017-06-30	Reported	-$24.88M	(m)	(m)	(m)	-73.71%	$230.00K*	(m)	(m)	$38.34M	$13.10M	$180.00K
2017-03-31	Reported	-$26.92M	(m)	(m)	(m)	-91.06%	$99.00K	(m)	(m)	$36.94M	$12.62M	$210.00K
2016-12-31	Reported	-$21.93M	(m)	(m)	(m)	-56.23%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$22.04M	(m)	(m)	(m)	-69.20%	$424.00K*	(m)	(m)	$33.86M	$11.60M	$1.28M
2016-06-30	Reported	-$21.12M	(m)	(m)	(m)	-63.36%	$1.17M*	(m)	(m)	$35.53M	$11.22M	$300.00K
2016-03-31	Reported	-$15.68M	(m)	(m)	(m)	-36.89%	$1.10M	(m)	(m)	$40.10M	$10.81M	$0.00
2015-12-31	Reported	$5.92M	(m)	(m)	(m)	11.34%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$22.84M*	-$23.24M	$402.00K*	(m)	(m)	$336.00K*	(m)	(m)	$27.61M	$10.23M	$0.00
2015-06-30	Reported	$4.63M*	$4.23M	$395.00K*	(m)	(m)	$260.00K*	$8.94M*	(m)	$21.20M	$9.81M	$0.00
2015-03-31	Reported	-$13.49M	(m)	(m)	(m)	-72.27%	$130.00K	-$13.84M	(m)	$16.68M	$9.40M	(m)
2014-12-31	Reported	-$3.39M	(m)	(m)	(m)	-11.17%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$18.56M*	-$19.03M	$464.00K*	(m)	(m)	$371.00K*	-$13.18M*	(m)	$19.90M	$8.59M	(m)
2014-06-30	Reported	-$14.50M*	-$14.94M	$443.00K*	(m)	(m)	$350.00K*	-$15.77M*	(m)	$18.65M	$8.75M	(m)
2014-03-31	Reported	-$24.82M	(m)	(m)	(m)	-207.44%	$411.00K	-$17.63M	(m)	$21.41M	$10.25M	(m)
2013-12-31	Reported	-$20.99M	(m)	(m)	(m)	-167.95%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$18.19M*	-$18.49M	$301.00K*	(m)	(m)	$325.00K*	-$12.41M*	(m)	$25.69M	$8.13M	(m)
2013-06-30	Reported	-$21.82M*	-$22.12M	$297.00K*	(m)	(m)	$80.00K*	-$10.96M*	(m)	$27.99M	$7.30M	(m)
2013-03-31	Reported	-$18.2M	(m)	(m)	(m)	-153.79%	$534.00K	-$10.75M	(m)	$22.03M	$7.56M	(m)
2012-12-31	Reported	-$4.12M	(m)	(m)	(m)	-18.92%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$19.74M*	-$20.03M	$286.17K*	(m)	(m)	$167.52K*	-$14.30M*	(m)	$19.50M	$5.63M	(m)
2012-06-30	Reported	-$13.78M*	-$14.05M	$272.20K*	(m)	(m)	$705.65K*	-$13.76M*	(m)	$16.08M	$5.58M	(m)
2012-03-31	Reported	-$14.9M	(m)	(m)	(m)	-200.30%	$0.00	-$19.36M	(m)	$15.89M	$6.62M	(m)
2011-12-31	Reported	-$18.18M	(m)	(m)	(m)	-754.15%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	$5.39M*	$5.15M	$238.68K*	(m)	(m)	$38.96K*	-$13.44M*	(m)	$13.51M	$4.26M	(m)
2011-06-30	Reported	$3.38M*	$3.10M	$286.75K*	(m)	(m)	$29.54K*	$3.74M*	(m)	$15.35M	$4.57M	(m)
2011-03-31	Reported	-$9.33M	(m)	(m)	(m)	-123.72%	$203.02K	-$11.09M	(m)	$13.79M	$3.41M	(m)
2010-12-31	Reported	-$17.54M	(m)	(m)	(m)	-490.97%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$12.07M*	-$12.43M	$364.53K*	(m)	(m)	$60.64K*	-$11.62M*	(m)	$12.45M	$3.37M	(m)
2010-06-30	Reported	(m)	-$12.15M	(m)	(m)	(m)	(m)	(m)	(m)	$11.92M	$3.36M	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$480.4M	(m)	(m)	(m)	34.40%	$6.97M	$651.56M	$228.77M	(m)	$207.09M	$149.99M
2024-12-31	Reported	$561.74M	(m)	(m)	(m)	55.33%	$10.70M	$479.06M	$159.42M	$79.05M	$154.34M	$113.04M
2023-12-31	Reported	$348.66M	(m)	(m)	(m)	42.04%	$15.29M	$388.57M	$192.36M	$76.36M	$149.18M	$66.73M
2022-12-31	Reported	$274.02M	(m)	(m)	(m)	41.51%	$4.81M	$240.11M	$139.30M	$66.61M	$143.53M	$46.79M
2021-12-31	Reported	$278.9M	(m)	(m)	(m)	62.91%	$1.46M	$299.44M	$81.41M	$35.67M	$50.32M	-$154.19M
2020-12-31	Reported	$147.54M	(m)	(m)	(m)	55.14%	$2.50M	$55.45M	$43.37M	$34.24M	$45.74M	$217.00K
2019-12-31	Reported	-$63.54M	(m)	(m)	(m)	-32.42%	$4.04M	-$85.42M	$45.55M	$140.80M	$77.25M	-$11.00K
2018-12-31	Reported	-$66.94M	(m)	(m)	(m)	-44.08%	$4.66M	-$49.50M	$10.14M	$150.25M	$60.80M	$537.00K
2017-12-31	Reported	$83.16M	(m)	(m)	(m)	26.27%	$1.35M	$134.05M	$31.15M	$150.64M	$53.82M	-$1.36M
2016-12-31	Reported	-$80.8M	(m)	(m)	(m)	-55.08%	$3.14M	-$50.38M	(m)	$150.84M	$45.85M	$1.16M
2015-12-31	Reported	-$25.78M	(m)	(m)	(m)	-19.08%	$2.36M	-$37.08M	(m)	$93.24M	$40.03M	$0.00
2014-12-31	Reported	-$61.27M	(m)	(m)	(m)	-81.34%	$1.37M	-$47.52M	(m)	$79.70M	$35.94M	$0.00
2013-12-31	Reported	-$79.21M	(m)	(m)	(m)	-144.54%	$2.30M	-$49.34M	(m)	$96.64M	$32.35M	(m)
2012-12-31	Reported	-$52.55M	(m)	(m)	(m)	-124.15%	$1.41M	-$64.28M	(m)	$70.04M	$24.81M	(m)
2011-12-31	Reported	-$18.74M	(m)	(m)	(m)	-33.42%	$828.51K	-$34.30M	(m)	$57.56M	$18.10M	(m)
2010-12-31	Reported	-$52.75M	(m)	(m)	(m)	-387.18%	$646.54K	-$45.39M	(m)	$51.77M	$15.12M	(m)
2009-12-31	Reported	-$57.01M	(m)	(m)	(m)	-417.04%	$1.46M	-$40.15M	(m)	$56.61M	$15.20M	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78